| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 01/20/2005 | WO2005005374A1 Aspartyl protease inhibitors |
| 01/20/2005 | WO2005004802A2 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/20/2005 | WO2005004796A2 Sulfonylamino phenylacetamide derivatives and methods of their use |
| 01/20/2005 | WO2004106411A3 Biodegradable poly(beta-amino esters) and uses thereof |
| 01/20/2005 | WO2004099124A3 Novel bioisosteres of actinonin |
| 01/20/2005 | WO2004083208A8 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 01/20/2005 | US20050014941 Cyanoalkylamino derivatives as protease inhibitors |
| 01/20/2005 | US20050014840 Thiol sulfonamide metalloprotease inhibitors |
| 01/20/2005 | US20050014822 Carbonylamino-substituted acyl phenyl urea derivatives, process for their preparation and their use |
| 01/20/2005 | US20050014791 Inhibitors of papilloma virus |
| 01/20/2005 | US20050014787 5-amidino-2-hydroxybenzenesulfonamide derivatives medicinal compoistions containing the same medicinal use thereof and intermediates in the production thereof |
| 01/20/2005 | US20050014740 E.g. 4-[2-(4-Methylphenoxy)- or 4-[2-(4-Methylphenylsulfanyl)-phenyl]-3,6-dihydro-2H-pyridine or piperazine or hydrochloride or oxalate; treating depression, anxiety, and obsessive compulsive disorders |
| 01/20/2005 | US20050014721 reacting oxabenzonorbornadiene with nucleophiles;in presence of rhodium complex catalyst forming 2-pyrrolidin-1-ol-1,2-dihydronaphthalen-1-ol; drug used as analgesics, Parkinson's disease, anticancer agents; aids |
| 01/20/2005 | US20050014702 Inhibition of pdf enzyme as bactericidal agents for veterinary medicines |
| 01/20/2005 | CA2531787A1 Sulfonamide derivatives as 5ht7 receptor antagonists |
| 01/20/2005 | CA2530538A1 Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
| 01/20/2005 | CA2529994A1 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/20/2005 | CA2529739A1 Aspartyl protease inhibitors |
| 01/19/2005 | EP1498406A1 Novel hydronaphthalene compounds, prepared by a rhodium catalysed ring opening reaction in the presence of phosphine ligand |
| 01/19/2005 | EP1498126A1 Neurotrophic factor production accelerator |
| 01/19/2005 | EP1497274A2 Terphenyl derivatives, preparation thereof, compositions containing same |
| 01/19/2005 | EP1497273A2 Hydroxamic acid derivatives |
| 01/19/2005 | EP1497270A1 Amide compounds and methods of using the same |
| 01/19/2005 | EP1497268A2 Nitric oxide donors, compositions and methods of use |
| 01/19/2005 | EP1497262A1 Acyl-4-carboxyphenylurea derivatives, method for production and use thereof |
| 01/19/2005 | EP1497260A1 Novel methoxybenzamide compounds for use in mch receptor related disorders |
| 01/19/2005 | EP1497256A1 Substituted 1,5-diaminopentan-3-ol compounds |
| 01/19/2005 | EP1496904A1 Pharmaceutical containing n, n'-disubstituted piperazine compounds |
| 01/19/2005 | EP1496890A1 Substituted beta-aminoalcohols used as medicaments |
| 01/19/2005 | EP1496838A2 Substituted amides |
| 01/19/2005 | EP1294657B1 Catalysis using phosphine oxide and sulfoxide compounds |
| 01/19/2005 | CN1566105A Chemical synthesis of 1-chloroformyl-4-methylpiperazine hydrochloride |
| 01/19/2005 | CN1566065A Alpha position heteroatom substituted gamma aryl ketobutyric acid derivative, process, pharmaceutical combination and uses thereof |
| 01/19/2005 | CN1185211C Benzamide derivatives for the treatment of diseases resulted from cytokines |
| 01/19/2005 | CN1185209C Preparation method of o-chloromethyl phenyl diglycolic acid derivative |
| 01/19/2005 | CN1185208C Preparation method of o-chloromethyl phenyl diglycolic acid derivative |
| 01/18/2005 | US6844446 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
| 01/18/2005 | US6844299 Polyol ester derivatives of polyamines and use in turbine oils to improve cleanliness |
| 01/18/2005 | US6844003 Compounds derived from benzoic acid esters, composition containing said compounds and use thereof |
| 01/13/2005 | WO2005003108A1 Quaternary ammonium salt, electrolyte, and electrochemical device |
| 01/13/2005 | WO2005002582A2 Trp-p8 active compounds and therapeutic treatment methods |
| 01/13/2005 | WO2004099134A3 Glutaminyl based dp iv-inhibitors |
| 01/13/2005 | WO2003084922A8 Acyl-4-carboxyphenylurea derivatives, method for production and use thereof |
| 01/13/2005 | US20050010060 Novel quinones as disease therapies |
| 01/13/2005 | US20050010045 Reacting morpholine compound with a substituted benzene compound |
| 01/13/2005 | US20050009872 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
| 01/13/2005 | US20050009871 Ubiquitin ligase inhibitors |
| 01/13/2005 | US20050009838 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/13/2005 | US20050009816 Potassium channel modulators |
| 01/13/2005 | US20050009799 Cyclohexyl derivatives as selective estrogen receptor modulators |
| 01/13/2005 | US20050009706 Herbicides; plant safening agents |
| 01/13/2005 | US20050008568 Complex containing dithiocarbamate compound |
| 01/13/2005 | CA2530884A1 Trp-p8 active compounds and therapeutic treatment methods |
| 01/12/2005 | EP1495009A2 Cyanamides useful as reversible inhibitors of cysteine proteases |
| 01/12/2005 | EP1495002A1 Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/12/2005 | EP1494997A1 Substituted aryl amides |
| 01/12/2005 | EP1494989A2 Compounds that modulate ppar activity and methods for their preparation |
| 01/12/2005 | EP1494674A1 Carboximide derivatives as useful uro-selective alpha-1a adrenoceptor blockers |
| 01/12/2005 | EP1494670A1 Medicine for treating cancer |
| 01/12/2005 | EP1494654A1 Palatable chewable tablet |
| 01/12/2005 | EP1171423B1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands |
| 01/12/2005 | CN1564811A Acylsulfonamides as inhibitors of steroid sulfatase |
| 01/12/2005 | CN1562988A Method for synthesizing Lomerizine Hydrochlortde |
| 01/11/2005 | US6841682 Prevent binding of adrenergenic receptors |
| 01/11/2005 | CA2192555C 2-acylaminopropanol compound and medicinal composition |
| 01/06/2005 | WO2005000845A2 Bicyclic derivatives as nk-1 and nk-2 antagonists |
| 01/06/2005 | WO2005000826A1 Urea derivatives of piperazines and piperidines as fatty acid oxidation inhibitors |
| 01/06/2005 | WO2005000822A1 N-{‘4-substituted piperazine-1-sulfonylmethyl!alkyl}-n-hydroxyfomamide compounds as metalloproteinase inhibitors |
| 01/06/2005 | WO2005000778A1 Hsp90 FAMILY PROTEIN INHIBITORS |
| 01/06/2005 | WO2005000775A2 Cyclohexyl derivatives as selective estrogen receptor modulators |
| 01/06/2005 | WO2005000309A2 Chemical compounds |
| 01/06/2005 | WO2004103967A3 Thiocarbamate inhibitors of alpha-4 integrins |
| 01/06/2005 | US20050004351 Therapeutic and diagnostic domain 1 beta2GP1 polypeptides and methods of using same |
| 01/06/2005 | US20050004164 2-Cyanopropanoic acid amide and ester derivatives and methods of their use |
| 01/06/2005 | US20050004139 Pharmaceutical preparations containing aminobenzene-sulfonic acid derivatives as the active ingredient |
| 01/06/2005 | US20050004136 Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful as neurokinin receptor modulators |
| 01/06/2005 | US20050004118 Prodrugs of non-steroidal anti-inflammatory and carboxylic acid containing compounds |
| 01/06/2005 | US20050004112 C-fms kinase inhibitors |
| 01/06/2005 | US20050004086 Indene derivatives as pharmaceutical agents |
| 01/06/2005 | US20050003230 cyclized; organic light-emitting diodes (OLED); eliminate drawbacks of Alq3 as emitter and a host material for dopants; narrower emission bands; broad spectral range; low driver voltages; high photometric efficiency (low power consumption); high luminance (emission intensity); high thermal stability |
| 01/06/2005 | US20050000791 Process for fractionating water-containing crude amine mixtures from amine synthesis |
| 01/06/2005 | CA2530376A1 Urea derivatives of piperazines and piperidines as fatty acid oxidation inhibitors |
| 01/06/2005 | CA2529468A1 N-{[4-substituted piperazine-1-sulfonylmethyl]alkyl}-n-hydroxyfomamide compounds as metalloproteinase inhibitors |
| 01/06/2005 | CA2527659A1 Cyclohexyl derivatives as selective estrogen receptor modulators |
| 01/05/2005 | EP1493743A1 Substituted bipiperidine intermediates and derivatives thereof |
| 01/05/2005 | EP1493742A1 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders |
| 01/05/2005 | EP1493731A1 N-benzyl-p-phenylenediamine-derivatives containing colouring agents for keratin fibres and these derivatives |
| 01/05/2005 | EP1492782A1 Piperazinyl- or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase |
| 01/05/2005 | EP1492781A1 N,n'-disubstituted piperazine compounds and the use of the same as analgesics |
| 01/05/2005 | EP1492776A2 Iodinated triglyceride analogs |
| 01/05/2005 | EP1492763A1 Carboxamidine derivatives and their use in the treatment of vascular diseases |
| 01/05/2005 | EP1492757A1 (2-((2-alkoxy)-phenyl)-cyclopent-1-enyl) aromatic carbo- and heterocyclic carboxylic acid and derivatives |
| 01/05/2005 | EP1492534A1 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
| 01/05/2005 | EP1492518A2 Tuberculosis treatment using pleuromutilin derivatives |
| 01/05/2005 | CN1561336A Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 01/05/2005 | CN1561327A Novel aminobenzoephenones |
| 01/05/2005 | CN1560041A Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 01/05/2005 | CN1183122C Dipeptide nitrile cathepsin K inhibitors |
| 01/05/2005 | CN1183119C Arylpiperzines as metalloproteinase inhibiting agents (MMP) and their use |
| 01/05/2005 | CN1183107C Alkynyl containing hydroxamic acid compounds as TACE inhibitors |